L2M- Neuromod, non-invasive brain stimulation and augmented reality sensorimotor training to treat chronic musculoskeletal pain

Neuromod is a revolutionary pain treatment designed to help improve the quality of life of the ~4 million Canadians living with chronic musculoskeletal (MSK) pain. Chronic MSK pain represents a major healthcare challenge due to the severity of pain, its impact on the individual, family, and Canadian Healthcare system. Current therapies for chronic MSK pain are a ‘band-aid approach’, focused on symptoms rather than targeting the underlying mechanism of pain. As a result, these therapies provide minimal to no relief and are associated with severe side effects. Therefore, there is a need for effective chronic MSK pain treatment options that are non-invasive, target the mechanism of pain, and have minimal side effects. Neuromod uses a non-invasive form of brain simulation and virtual form of physiotherapy, called augmented reality sensorimotor training. These techniques combine to block pain signals and retrain how the brain controls movement in the affected area. In this way, Neuromod targets the mechanism of chronic musculoskeletal pain to alleviate pain. This program represents an excellent opportunity to engage with and learn from stakeholders and other individuals involved in healthcare commercialization. I will have the opportunity to meet with stakeholders including physicians, physiotherapists, and people with lived experience to further understand the market potential for our treatment and refine its delivery. In addition, the commercialization of healthcare innovations face unique challenges associated with regulations of medical devices and its use as a therapeutic. This program will allow me to understand the regulations required to offer Neuromod as a therapy.

Faculty Supervisor:

Aimee Nelson

Student:

Partner:

Springboard Atlantic Inc.

Discipline:

Engineering

Sector:

Health and Related Sciences & Technology

University:

McMaster University

Program: